Investigational Site 022 — Endwell, New York

Investigational Site 022 is a clinical research site located in Endwell, New York, United States 13760.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 022 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 022?

Investigational Site 022 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 022 conducted?

Investigational Site 022 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Investigational Site 022 accredited by Crixeo Health?

Investigational Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.